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ABSTRACT
Objectives: The aim of this study was to assess the
risk of incident rheumatological diagnoses (RD)
associated with self-reported diarrhoea and vomiting
during a first-time deployment to Iraq or Afghanistan.
Such an association would provide evidence that RD in
this population may include individuals with reactive
arthritis (ReA) from deployment-related infectious
gastroenteritis.
Design: This case–control epidemiological study used
univariate and multivariate logistic regression to compare
the odds of self-reported diarrhoea/vomiting among
deployed US military personnel with incident RD to the
odds of diarrhoea/vomiting among a control population.
Setting:We analysed health records of personnel
deployed to Iraq or Afghanistan, including responses on
a postdeployment health assessment and medical follow-
up postdeployment.
Participants: Anonymous data were obtained from 891
US military personnel with at least 6 months of medical
follow-up following a first-time deployment to Iraq or
Afghanistan in 2008–2009. Cases were defined using
International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) diagnosis codes;
controls had an unrelated medical encounter and were
representative of the study population.
Main outcome measures: The primary measure was
an association between incident RD and self-reported
diarrhoea/vomiting during deployment. A secondary
measure was the overall incidence of RD in this
population.
Results:We identified 98 cases of new onset RD, with a
total incidence of 161/100 000 persons. Of those, two
participants had been diagnosed with Reiter’s diseasei
(3.3/100 000 persons) and the remainder with non-
specific arthritis/arthralgia (157.5/100 000 persons). The
OR for acute diarrhoea was 2.67 (p=0.03) after adjusting
for important covariates.
Conclusions: Incident rheumatological conditions,
even those classified as ‘non-specific,’ are significantly
associated with prior severe diarrhoea in previously
deployed military personnel, potentially indicating ReA
and need for preventive measures to reduce
diarrhoeagenic bacterial exposures in military personnel
and other travellers to the developing regions.
INTRODUCTION
Travellers’ diarrhoea (TD) is common
among those travelling from the developed
to the developing regions of the world.
Incidence is broadly estimated at 20–40% of
travellers per month but varies by country
or region visited, duration of travel and
sociodemographic factors.1–3 The aetiology
of TD is predominantly bacterial, commonly
caused by diarrhoeagenic Escherichia coli,
Campylobacter spp., Shigella spp. and non-
typhoidal Salmonella spp., although viral and
parasitic infections also occur.3–5 While the
Strengths and limitations of this study
▪ Use of self-reported gastroenteritis instead of
medical encounter data or culture-confirmed
infectious gastroenteritis enabled inclusion of a
larger portion of personnel potentially exposed
to pathogens of interest.
▪ Extraction of data from a health assessment
completed by all military personnel returning
from deployment allowed access to a large pool
of respondents.
▪ Broadly defining reactive arthritis by the specific
and non-specific International Classification of
Diseases, Ninth Revision, Clinical Modification
codes increased the sensitivity.
▪ Each of these study design decisions introduced
the possibility of non-differential biases, includ-
ing exposure misclassification, recall bias and
outcome misclassification. This would likely bias
the associations towards the null.
iThe terms Reiter’s disease and Reiter’s syndrome are
being replaced with the more appropriate term Reactive
Arthritis. Usage in this article strictly refers to their
use in the International Classification of Diseases, Ninth
Revision, Clinical ModificationICD-9-CM diagnostic
codes (099.3 and 711.1) and is not an endorsement of
the terms.
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acute symptoms associated with TD are predominately
self-limited and may be shortened in duration by anti-
biotic therapy, sequelae associated with infection by
pathogens of TD can cause long-term gastrointestinal,
neurological and rheumatological health outcomes.6–8
Reactive arthritis (ReA) is a sterile asymmetric arthritis
of one or more joints that can include inflammation of
the tendons, eyes, genitourinary tract and skin.9 Joint
inflammation is most common in the large joints of the
lower limbs.9 10 The most strongly associated enteric bac-
teria are Campylobacter jejuni and coli, non-typhoidal
Salmonella spp, Shigella spp and Yersinia enterocolitica.9–13
Reports of ReA following bacterial gastroenteritis are
most common following large-scale outbreaks, and esti-
mates of incident ReA outcomes range from 0% to 30%
depending on the infecting pathogen, host characteris-
tics, outcome definitions and other factors.10 14
Deployed military personnel represent a young, pre-
dominately healthy subset of the general travel popula-
tion at high risk of TD and, potentially, of related
sequelae. Given the prior reports of an increased risk of
functional gastrointestinal disorders following infectious
gastroenteritis during military deployment and a twofold
increased risk of Reiter’s diseasei and postdysenteric
arthropathy among personnel deployed to high-risk
regions, we sought to assess the risk of incident rheum-
atological diagnoses (RD) associated with self-reported
diarrhoea and vomiting during a first-time deployment
to Iraq or Afghanistan.15 16
METHODS
A case–control study of military personnel was designed
to compare the odds of self-reported diarrhoea or vomit-
ing during deployment among personnel with incident
RD (cases) to the odds among those without such diag-
noses (controls). All participants were active duty US
military personnel on initial deployment between 2008
and 2009 with at least 6 months of postdeployment
medical follow-up (figure 1). Cases were identified using
International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) codes for Reiter’s
diseasei (099.3 and 711.1), postdysenteric arthropathy
(711.3) and, due to the confounding factors underlying
Reiter’s diseasei diagnoses, a category of non-specific
arthritis/arthralgia (NAA) was included (716.4-.6,
716.8-.9).10 16 17 The ICD-9-CM codes for postdysenteric
arthropathy and non-specific arthritis/arthropathy
include a fifth digit subclassification indicating the body
area affected (figure 2). Cases required a minimum of
Figure 1 Schema of selection for analysis.
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two separate outcome-specific medical encounters
within 365 days with no concurrent diagnoses of
Chlamydia trachomatis, Neisseria gonorrhoeae or Ureaplasma
urealyticum. Controls were of a similar age, deployment
location (Iraq or Afghanistan), had an unrelated
medical encounter and were representative of the study
population.
All data were obtained from the Defense Medical
Surveillance System (DMSS), a repository for medical
surveillance data on US military personnel.18
Demographic variables, including age, gender, race,
rank and marital status were analysed to assess their
association with incident RD. Because acute enteric
infections are under-reported through electronic
medical records, exposure data were obtained from
postdeployment health assessments (PDHAs), a self-
administered survey completed by all US military person-
nel returning from deployment. Of specific interest for
this study were questions about diarrhoea and vomiting
during deployment. Respondents indicated whether
during deployment, they had seen a healthcare provider
for and/or had been ordered to remain in their quarters
(bed rest) or placed on medically restricted duty status
(light/limited duty) for diarrhoea or vomiting. Personnel
who consistently did not respond to the exposure ques-
tions were excluded from the case–control analysis; for
those who answered at least one exposure question, we
considered missing responses as ‘no’ responses.
The incidence of RD was calculated based on the
number of active duty US military personnel eligible for
inclusion into this study. Multivariate logistic regression
models were developed utilising a backward elimination
approach in which all covariates were initially included.
The final adjusted model was developed iteratively for
the outcome of any diarrhoea or vomiting during
deployment, and only variables with α≤ 0.15 were
retained. The final model was then applied to each
exposure strata. Reference groups were chosen based on
prior epidemiological studies as well as distribution of
our data. Statistical analyses were conducted using SAS
V.9 for Windows (SAS Institute, Cary, North Carolina,
USA) and interpreted using α=0.05.
Figure 2 Fifth digit
subclassification of body area
affected.
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The study protocol was approved by the Naval Medical
Research Center Institutional Review Board in compli-
ance with all applicable Federal regulations governing
the protection of human participants.
RESULTS
We identified 98 cases of new onset RD among active
duty military personnel with an initial deployment to
Iraq and/or Afghanistan between 2008 and 2009 for a
total incidence of 161/100 000 persons (figure 1). Two
cases were diagnosed with Reiter’s diseasei (3.3/100 000
persons) and the rest with NAA (157.5/100 000
persons). Of the nine possible subclassifications, the
most frequently specified body areas affected were lower
leg (27%), shoulder (21%) and ankle/foot (21%); 18%
of diagnoses did not specify a body area (figure 2). The
remaining 13% were composed of pelvic region/thigh
(4.5%), forearm (2.4%), hand (0.9%), upper arm
(0.6%), and other (2.4%) or multiple (2.1%) sites.
Excluding primary exposure non-respondents (ie,
those who did not answer gastroenteritis questions)
yielded 891 participants: 68 cases and 823 controls
(figure 1). Overall, 28% of original participants were
non-respondents: 31% of cases and 28% of controls. As
intended, there was no difference in the average age of
cases or controls (mean 27.6 years; SD 6.8; table 1).
Compared with controls, cases were more predominately
male (94% vs 70%; p<0.001) and tended to be married
(60% vs 48%; p=0.06). The prevalence of self-reported
gastroenteritis was relatively low across deployments
(19.4%; table 2). However, personnel deployed to
Afghanistan reported diarrhoea and/or vomiting more
often than those deployed to Iraq (37% vs 17%, p=0.01).
Univariate logistic regression showed that male
gender (p<0.001) and rank (p=0.01) were associated
with increased incidence of rheumatological outcomes
(table 3). A greater per cent of cases than controls
reported care-seeking (23.5% vs 15.2%; p=0.07) and
being assigned light/limited duty (10.3% vs 5.0%
p=0.07) for diarrhoea. Black or white race (p=0.15),
junior officer rank (p=0.11) and being married
(p=0.06) were also more common among those with
RD. After adjusting for covariates, the prevalence of diar-
rhoea and vomiting was consistently higher among cases
than among controls (table 4). In personnel reporting
more severe diarrhoea (eg, being sick-in-quarters or
placed on light/limited duty), there was an approxi-
mately 2.5-fold increased odds of RD compared with
those who did not (aOR 2.67; p=0.03). Although the
association with milder diarrhoea was not statistically sig-
nificant, there was a trend suggestive of a dose–response
effect. Self-reported vomiting was not a significant pre-
dictor of incident RD.
Table 1 Demographic and exposure characteristics of US military service members after their first deployment to Iraq or
Afghanistan between 2008 and 2009
Variable Cases* (n=68) Controls (n=823) p Value
Mean age (SD) 28.5 (6.8) 27.5 (7.6) 0.26
Gender
Female 4 (6%) 244 (30%) <0.001
Male 64 (94%) 579 (70%)
Race
Black 15 (22%) 167 (20%) 0.72
White 45 (66%) 500 (61%)
Other 8 (12%) 156 (19%)
Rank
Enlisted 60 (88%) 702 (85%) 0.50
Officer/warrant officer 8 (12%) 121 (15%)
Marital status
Single/other 27 (40%) 426 (52%) 0.06
Married 41 (60%) 397 (48%)
Deployment region†
Afghanistan 7 (10%) 97 (12%)
Iraq 60 (90%) 721 (88%) 0.73
Gastroenteritis
Any diarrhoea/vomiting 19 (27.9%) 154 (18.7%) 0.07
Any diarrhoea 16 (23.5%) 131 (15.9%) 0.11
Sought care for diarrhoea 16 (23.5%) 125 (15.2%) 0.07
Limited duty status—diarrhoea 7 (10.3%) 41 (5.0%) 0.07
Any vomiting 9 (13.2%) 71 (8.6%0 0.21
Sought care for vomiting 8 (11.8%) 66 (8.0%) 0.29
Limited duty status—vomiting 4 (5.9%) 39 (4.7%) 0.67
*Diagnosed at least twice with ICD-9-CM codes meeting study criteria for incident RD within 365 days.
†Excludes six personnel who deployed to both regions. Case n=67, control n=818.
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DISCUSSION
We found that 16% of deployed service members sought
care for diarrhoea, 38% of whom required a change in
duty as a result of the acute illness. This is much lower
than prior estimates of gastroenteritis in deployed mili-
tary personnel.19 20 Specifically, Sanders et al19 found in
2004 that 77% of US personnel who served in Iraq and
54% of those deployed to Afghanistan reported any diar-
rheal illness; nearly half of those with diarrheal illness
had sought care. Differences in study methods may have
contributed to this difference. Use of a post-deployment
questionnaire in our study is likely to have resulted in
under-reporting of exposure, while Sanders et al utilised
active case-surveillance through mid-deployment and
post-deployment surveys to identify diarrheal cases.
However, this could also indicate a true decrease in inci-
dence due to decreased risk in theatre, which has been
reported in a previous publication.21
We identified an overall incidence of RD of 161/
100 000 (Reiter’s diseasei: 3.1/100 000 and NAA: 157.5/
100 000), similar to estimates reported by Curry et al.16
These estimates are greater than those from population-
based studies within the USA, likely due to differences
in study populations and methods utilised to classify
exposures and outcomes.11 In addition, exposure to spe-
cific bacterial pathogens in deployed populations is
likely more common than in the developed countries,
where viruses are the dominant cause of acute
Table 2 Frequency (n (%)) of self-reported, deployment-related exposures by deployment region (excluding six personnel
deployed to both regions)
Variable Afghanistan (n=104) Iraq (n=781) p Value
Any gastroenteritis 40 (38) 132 (17) 0.01
Any diarrhoea 33 (32) 114 (15) 0.28
Sought care for diarrhoea 32 (31) 109 (14) 0.39
Bed rest/light or limited duty status—diarrhoea 9 (9) 39 (5) 0.92
Any vomiting 17 (16) 62 (8) 0.29
Sought care for vomiting 15 (14) 58 (7) 0.19
Bed rest/light or limited duty status—vomiting 8 (8) 34 (4) 0.59
Table 3 Unadjusted conditional ORs (95% CIs) for exposure variables and covariates from univariate analysis evaluating
RD after first deployment to Iraq or Afghanistan between 2008 and 2009
Variable OR 95% CI p Value
Gender
Female 1.0
Male 6.74 2.48 to 18.71 <0.001
Race
Other 1.0
Black/white 1.75 0.82 to 3.74 0.15
Rank
Enlisted 1.0
Junior officer 0.43 0.15 to 1.22 0.11
Senior officer 11.70 1.62 to 84.54 0.01
Warrant officer 2.13 0.46 to 9.82 0.33
Marital status
Single/other 1.0
Married 1.63 0.98 to 2.70 0.06
Deployment*
Afghanistan 1.0
Iraq 1.15 0.512 to 2.595 0.73
Gastroenteritis
Any diarrhoea/vomiting 1.68 0.96 to 2.94 0.07
Any diarrhoea 1.68 0.96 to 2.94 0.11
Sought care for diarrhoea 1.72 0.95 to 3.11 0.07
Limited duty status—diarrhoea 2.19 0.94 to 5.09 0.07
Any vomiting 1.62 0.77 to 3.39 0.21
Sought care for vomiting 1.53 0.70 to 3.33 0.29
Limited duty status—vomiting 1.26 0.44 to 3.63 0.67
*Excludes six participants deployed to both Iraq and Afghanistan.
RD, rheumatological diagnoses.
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gastroenteritis.3 22 23 Importantly, the body areas
affected, primarily the lower leg, are consistent with
other reports of ReA.10 14 ReA is known to commonly
occur in multiple joints at once, but clinicians may have
chosen to specify only one body area because it was the
body area worst affected or because it was the body area
in which the condition had persisted until that medical
encounter.14
We found a nearly threefold increased risk (aOR 2.67,
95% CI 1.11 to 6.47) of exposure to severe diarrhoea
during deployment for RD, elaborating on the findings
by Curry et al16 of associations between prior infectious
gastroenteritis and/or deployment to high-risk regions
and Reiter’s disease or NAA. Using the same outcome
definitions, Curry et al reported an adjusted OR (aOR)
of 1.76 (95% CI 1.49 to 2.07) for NAA risk in those with
documented infectious gastroenteritis compared with
those without.
The incidence of RD in this study was higher than in
population-based studies, but possibly lower than the
incidence in all deployed personnel due to our relatively
young study population. Our sample was limited to per-
sonnel on first-time deployment, yielding a mean age of
27.6 years (SD 6.8); this is lower than the average age of
ReA diagnosis in the general population (30–40 years).10
Curry16 observed that the rates of NAA and ReA
increased significantly with age. In a prospective study of
culture-confirmed Campylobacter, E coli O157, Salmonella,
Shigella and Yersinia infections among patients >1 year,
Townes et al14 observed a median age of 41 years among
individuals with confirmed ReA. If younger persons are
less likely to develop ReA, our incidence estimate may
be lower than the incidence of ReA among all deployed
service members and the broader travel population.
Although these data may not be directly generalisable
to every travel population, our findings highlight ReA as
an important TD sequela among travellers who stay for
long periods in the developing regions of the world
where bacillary diarrhoea is common. However, this study
should be interpreted with a full appreciation of the
inherent limitations. In using self-reported gastroenteritis
instead of medical encounter data or culture-confirmed
infectious gastroenteritis, we were able to include a larger
portion of personnel potentially exposed to the patho-
gens of interest. This is especially important because
medical encounter data in the deployment setting are
not routinely recorded in electronic medical records
capable of being linked with ambulatory and inpatient
medical encounters. However, by using this exposure def-
inition, we may have included an undefined number of
non-bacterial gastroenteritis episodes resulting in expos-
ure misclassification—likely non-differential and thus
biasing towards the null. In addition, utilising data col-
lected at the end of deployment, potentially months after
the gastroenteritis episode, opened the study to non-
differential recall bias. Similarly, broadly defining ReA by
the specific and non-specific ICD-9-CM codes increased
sensitivity, but likely increased outcome misclassification.
ICD-9-CM codes are useful for health surveillance but
have several known sources of error and variance which
impact data reliability.24 25 Using the surveillance data
available from the DMSS expanded our access to poten-
tial research participants and their records. However,
response rates, particularly to the questions of interest in
this study, were poor. Only 69% of cases and 75% of con-
trols answered the gastroenteritis questions and the rest
could not be included in case–control analyses. This
design allowed us to examine the risk of ReA in active
duty military personnel, a group of people who have a
high rate of gastroenteritis and whose risk for ReA has
not been well studied.
Further research is needed to define the incidence,
risk factors, duration and costs of ReA in active duty mili-
tary personnel and other travel populations. Improved
characterisation of incidence and risk factors can be
accomplished with study designs targeting more well-
refined diagnoses of ReA and postdysenteric arthropa-
thy, case-finding that does not depend on ICD-9-CM
codes and more specific measures of bacterial gastro-
enteritis during travel than are available through the
PDHA. In a US military population, a longitudinal study
could utilise duration and cost of illness data extracted
from the DMSS. Our study suggests that a significant
proportion of individuals with ReA may currently be
Table 4 Adjusted* ORs (95% CIs) for exposure variables from multivariate analysis evaluating incident RD after first
deployment to Iraq or Afghanistan between 2008 and 2009
N (%)
Variable Cases Controls aOR* 95% CI p Value
Any diarrhoea/vomiting 19 (28) 154 (19) 1.65 0.92 to 2.96 0.09
Any diarrhoea 16 (24) 131 (16) 1.49 0.80 to 2.77 0.21
Sought care for diarrhoea 16 (24) 125 (15) 1.56 0.83 to 2.91 0.17
Quarters/light or limited duty status for diarrhoea 7 (10) 41 (5) 2.67 1.11 to 6.47 0.03
Any vomiting 9 (13) 71 (9) 1.91 0.89 to 4.11 0.10
Sought care for vomiting 8 (12) 66 (8) 1.83 0.82 to 4.08 0.14
Quarters/light or limited duty status for vomiting 4 (6) 39 (5) 1.76 0.59 to 5.29 0.31
*OR adjusted for gender, race, rank and marital status.
aOR, adjusted OR; N, number.
RD, rheumatological diagnoses.
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categorised as having NAA. This possibility should be
investigated by clinically examining patients in a variety
of target populations who have been diagnosed with
NAA to determine whether they have ReA. Prospective
studies expanding the work of Townes et al are warranted
to further study individuals from the time they are diag-
nosed with infectious gastroenteritis through the time
when some develop ReA.14 Consistent pathogen-specific
attributable risk estimates are also needed to elaborate
on the burden of ReA that could be eliminated through
improved bacterial gastroenteritis prevention.
We have shown an increase in incident RD in active
duty military personnel following severe diarrhoea
during deployment to Iraq and/or Afghanistan. Even in
a population of cases primarily diagnosed with NAA,
there was a significant association with self-reported diar-
rhoea during deployment. This seems to confirm that a
proportion of cases were experiencing ReA. Because our
study population primarily represented younger military
personnel and ReA is most common in 30-year-olds and
40-year-olds, the true incidence of ReA in active duty
military personnel and the broader travel population
may be higher than our estimate. Carefully designed
future studies will help to further characterise the risk
factors of ReA and its long-term health consequences
and to identify interventions that could reduce the
burden of chronic sequelae in at-risk travellers.
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